New hope to keep cancer treatment on track
Disease control
Not yet recruiting
This study is testing a new drug, Romiplostim N01, to see if it can safely and effectively raise platelet counts in cancer patients. Low platelets are a common and serious side effect of chemotherapy and radiation that can force doctors to delay or reduce treatment. The trial wil…
Phase: NA • Sponsor: Jun wang • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC